The future of HPAPIs according to industry insiders

By Natalie Morrison

- Last updated on GMT

Related tags: High potency apis, Pharmacology

High potency APIs are becoming a key focus of the pharmaceutical business, with drug makers from all areas racing to establish a foothold in the market.

From big pharma to generics manufacturers, it seems the molecules – which often prove to be more effective at smaller dosage levels than traditional APIs – are a highly sought after entity.

However, with the toxic nature of the ingredients, developing and manufacturing HPAPIs (high potency APIs) often presents companies with complex and sometimes unsolvable challenges.

Nevertheless companies such as Roche​, Solvias and RohnerChem​, and Carbogen Amcis​ are just a few of the firms that have recently waded further into the high potency market with new partnerships and facilities, signaling HPAPIs remain firmly on the horizon.

in-PharmaTechnologist asked the experts where they see the future of the business at last month’s AAPS conference in Washington.

GlaxoSmithKline’s (GSK) Allan Clarke, director of innovative manufacturing, spoke of the key role liquid media is now playing for the company.

And Dr. Reddy’s CPS Formulations project manager, Radha Srikrishna Maganti, told us how his firm is stressing the importance of classification of the molecules.

Related news

Show more

Related products

show more

How to resolve sticking issues in tablet production

How to resolve sticking issues in tablet production

I Holland Limited - Tabletting Science | 24-Jun-2019 | Case Study

Tablet sticking is one of the most common problems in tablet manufacture. Find out how I Holland used the TSAR scientific predictive model and expert tablet...

How to measure powder and granule flow properties

How to measure powder and granule flow properties

Stable Micro Systems | 01-Apr-2019 | Technical / White Paper

Being able to predict, optimise and control powder flow is of prime importance to manufacturers in ensuring high quality standards. Download this free...

Fill Release at the Right Time in the Right Place

Fill Release at the Right Time in the Right Place

Gelita AG | 19-Sep-2018 | Technical / White Paper

From rapid release in the stomach for e.g. analgesics to enteric release for fills with unpleasant aftertaste – GELITA delivers the respective gelatine...

Related suppliers